Showing results (91-100 of 1,988) with videos related to

Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|September 26, 2007
Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE databaseN Sadetsky, E P Elkin, D M Latini, et al.
Prostate Cancer and Prostatic Diseases|July 2, 2008
Prostatic fluid electrolyte composition for the screening of prostate cancer: a potential solution to a major problemL C Costello, R B Franklin
Prostate Cancer and Prostatic Diseases|September 19, 2007
Hepatocyte growth factor and interleukin-6 in combination with prostate volume are possible prostate cancer tumor markers in patients with gray-zone PSA levelsK Nishimura, N Arichi, S Tokugawa, et al.
Prostate Cancer and Prostatic Diseases|April 26, 2007
Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat modelY-M Cho, S Takahashi, M Asamoto, et al.
Prostate Cancer and Prostatic Diseases|April 26, 2007
Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patientsY Zhang, S S Forootan, D Liu, et al.
Prostate Cancer and Prostatic Diseases|June 29, 2019
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-upStefano Luzzago, Michele Catellani, Ettore Di Trapani, et al.
Prostate Cancer and Prostatic Diseases|June 1, 2019
Performance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysisShoji Kimura, Mohammad Abufaraj, Florian Janisch, et al.
Prostate Cancer and Prostatic Diseases|April 20, 2022
The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysisAlex Pozdnyakov, Roshini Kulanthaivelu, Glenn Bauman, et al.
Prostate Cancer and Prostatic Diseases|March 16, 2022
A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancerLandon C Brown, Susan Halabi, Jason A Somarelli, et al.
Prostate Cancer and Prostatic Diseases|March 20, 2022
Feasibility of home-based exercise training in men with metastatic castration-resistant prostate cancerErik D Hanson, Mohamdod Alzer, Jackson Carver, et al.
Pageof 199